First Trust Advisors LP Ultragenyx Pharmaceutical Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 17,022 shares of RARE stock, worth $761,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,022

Previous 281,093 93.94%

Holding current value

$761,734

Previous $11.6 Million 91.82%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.21 - $59.36 $10.6 Million - $15.7 Million	-264,071 Reduced 93.94%	17,022 $945,000
Q2 2024 Aug 13, 2024	SELL	$37.42 - $51.61 $3.26 Million - $4.5 Million	-87,126 Reduced 23.66%	281,093 $11.6 Million
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $34.2 Million - $42.7 Million	-794,858 Reduced 68.34%	368,219 $17.2 Million
Q4 2023 Feb 13, 2024	SELL	$31.73 - $49.19 $1.23 Million - $1.9 Million	-38,611 Reduced 3.21%	1,163,077 $55.6 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $1.64 Million - $2.19 Million	46,852 Added 4.06%	1,201,688 $42.8 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $2.16 Million - $3.01 Million	-57,780 Reduced 4.76%	1,154,836 $53.3 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $2.54 Million - $3.34 Million	68,644 Added 6.0%	1,212,616 $48.6 Million
Q4 2022 Feb 09, 2023	BUY	$33.72 - $46.33 $15.5 Million - $21.3 Million	459,628 Added 67.16%	1,143,972 $53 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $4.74 Million - $7.85 Million	118,699 Added 20.98%	684,344 $28.3 Million
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $7.24 Million - $13.5 Million	-158,113 Reduced 21.85%	565,645 $33.7 Million
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $1.17 Million - $1.59 Million	-18,883 Reduced 2.54%	723,758 $52.6 Million
Q4 2021 Feb 08, 2022	BUY	$73.71 - $87.86 $1.88 Million - $2.24 Million	25,533 Added 3.56%	742,641 $62.4 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $9.6 Million - $12.6 Million	123,165 Added 20.74%	717,108 $64.7 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $3.26 Million - $4.09 Million	35,364 Added 6.33%	593,943 $56.6 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $21.9 Million - $34.4 Million	-205,226 Reduced 26.87%	558,579 $63.6 Million
Q4 2020 Feb 02, 2021	SELL	$84.4 - $177.39 $14.7 Million - $30.8 Million	-173,709 Reduced 18.53%	763,805 $106 Million
Q3 2020 Nov 05, 2020	SELL	$72.98 - $90.0 $17.1 Million - $21.1 Million	-234,195 Reduced 19.99%	937,514 $77.1 Million
Q2 2020 Jul 22, 2020	BUY	$46.91 - $78.22 $10.6 Million - $17.6 Million	225,205 Added 23.79%	1,171,709 $91.7 Million
Q1 2020 May 06, 2020	SELL	$33.8 - $62.9 $8.16 Million - $15.2 Million	-241,459 Reduced 20.33%	946,504 $42.1 Million
Q4 2019 Feb 03, 2020	BUY	$36.08 - $45.83 $6.81 Million - $8.65 Million	188,797 Added 18.9%	1,187,963 $50.7 Million
Q3 2019 Nov 04, 2019	SELL	$42.5 - $63.11 $21.9 Million - $32.6 Million	-516,029 Reduced 34.06%	999,166 $42.7 Million
Q2 2019 Jul 30, 2019	SELL	$54.93 - $74.36 $18.9 Million - $25.6 Million	-343,857 Reduced 18.5%	1,515,195 $96.2 Million
Q1 2019 May 09, 2019	BUY	$39.87 - $69.36 $15.4 Million - $26.9 Million	387,118 Added 26.3%	1,859,052 $129 Million
Q4 2018 Feb 07, 2019	BUY	$38.89 - $77.3 $8.11 Million - $16.1 Million	208,468 Added 16.5%	1,471,934 $64 Million
Q3 2018 Oct 25, 2018	BUY	$71.81 - $90.15 $20.5 Million - $25.8 Million	285,961 Added 29.25%	1,263,466 $96.5 Million
Q2 2018 Aug 02, 2018	BUY	$48.54 - $85.31 $811,249 - $1.43 Million	16,713 Added 1.74%	977,505 $75.1 Million
Q1 2018 Apr 23, 2018	BUY	$44.33 - $58.52 $7.76 Million - $10.2 Million	175,098 Added 22.29%	960,792 $49 Million
Q4 2017 Feb 08, 2018	BUY	$43.54 - $57.32 $11.3 Million - $14.9 Million	259,816 Added 49.41%	785,694 $36.4 Million
Q3 2017 Oct 24, 2017	BUY	$49.79 - $66.32 $26.2 Million - $34.9 Million	525,878	525,878 $28 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Ultragenyx Pharmaceutical Inc. Transaction History